Registration

THE RABEN GROUP for AMGEN U.S.A. INC

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Science/Technology SCI

Lobbying in support of HR 1548 and S 726, the Pathways for Biologics Act, to promote patient safety while supporting the development of biologics.

LobbyistCovered position, as disclosed
LICY DO CANTO New —
LAWRENCE FRANCISCO GONZALEZ New —
MEAGHAN FRANCES HOHL New —
ROBERT RABEN New —

Bills named: H.R. 1548 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.